Dr. Lucien A. Nedzi, M.D.

Expert Publications

• Abnormal nuclear morphology of leukocytes in the mouse mutant ichthyosis.
• The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: observations on efficacy and toxicity in clinical practice.
• Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.
• Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects.
• A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck.

Media Releases

Get to know Radiation Oncologist Dr. Lucien A. Nedzi, who serves patients in Dallas, Texas.

Dr. Nedzi is a board-certified radiation oncologist who joined UT Southwestern Medical Center in March of 2008 as an Associate Professor of Radiation Oncology, Vice Chair for Clinical Affairs, and Medical Director. UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty includes many distinguished members, including six who have been awarded Nobel Prizes since 1985. The faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments.

Prior to joining the UT Southwestern faculty, Dr. Nedzi held faculty appointments at both Tulane University and Louisiana State University in New Orleans. He still enjoys spending time in the Big Easy whenever possible.

Dr. Nedzi focuses his practice primarily on the treatment of brain cancers and brain metastases. Motivated by the need to find better cures, he has been an active clinical investigator throughout his career, leading clinical trials at UT Southwestern, as well as throughout the nation.

Dr. Nedzi earned his medical degree from the University of California, San Francisco in 1987. He then went on to complete his internship in internal medicine at Beth Israel Deaconess Medical Center in 1988, followed by his fellowship at the Harvard Joint Center for Radiation Therapy in 1990. He also completed his residency in radiation oncology at the Harvard Joint Center for Radiation Therapy in 1992. 

Dr. Nedzi is board-certified in radiation oncology by the American Board of Radiology (ABR). The ABR is a not for profit physician-led organization. It oversees the certification and ongoing professional development of specialists in diagnostic radiology, radiation oncology, and medical physics.

Dr. Nedzi has published numerous articles in medical journals, including the American Journal of Medical Science and Otolaryngology – Head and Neck Surgery. His contributions include several articles on the subject of stereotactic radiosurgery. He is also the co-author of a leading textbook on stereotactic body radiation therapy. Additionally, Dr. Nedzi was named a Super Doctor by Texas Monthly in 2018.

Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. A radiation oncologist, like Dr. Nedzi, is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. He specializes in radiation therapy for brain tumors and spinal cord cancer.

Recommended Articles

• Bone Health Drugs for Breast Cancer

  Like any other drug or therapy, breast cancer treatment also has its own side effects. One of the side effects of breast cancer treatment is rapid bone loss leading to osteoporosis. The following are treatments for breast cancer that can significantly cause bone loss:...

• The Most Common Misconceptions About Breast Cancer

  There is so much information you can read online about breast cancer. Some information may be acquired in the community, friends, or family that is totally misleading or incorrect. Although not backed up with solid evidence, such information can cause a lot of media attention, which can further...

• Three-Week Chemotherapy Dosing Reconfirmed as First-Line Treatment of Ovarian Cancer

  Chemotherapy as a treatment option for cancer has existed for decades, and has long been the standard of care and first line of treatment for almost all forms of cancer. The term is an umbrella term referring to the use of medicines to halt the growth of cancerous tumors and to kill off cancerous...

• Financially Managing Lymphoma Care

  If you are living with lymphoma, one of your main concerns may be the payment charges that seem to be piling up too quickly. It can be stressful enough living with cancer, let alone having to worry about going into debt. For this reason, it is important to become aware of the different expenses...

• What Procedures Are Used to Treat Bladder Cancer?

  There are various treatment options for bladder cancer. Each option has its own procedure on how it is carried out. The type of treatment is also chosen based on several factors such as:...

• Treatment Options for Cervical Cancer

  Cervical cancer is one of the most common types of cancer in women. However, unlike the other forms of cancer, cervical cancer can be cured if it is discovered early on. That’s why cervical screening tests are necessary.Cervical cancer usually has no apparent symptoms in the primary stages. The...